UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 55

Sortiert nach

Discovery of 4-ethoxy-7H-pyrrolo[2,3-d]pyrimidin-2-amines as potent, selective and orally bioavailable LRRK2 inhibitors

Bioorganic & medicinal chemistry letters, 2018-05, Vol.28 (9), p.1615-1620

2018

Volltextzugriff (PDF)

5-Substituted-N-pyridazinylbenzamides as potent and selective LRRK2 inhibitors: Improved brain unbound fraction enables efficacy

Bioorganic & medicinal chemistry letters, 2019-01, Vol.29 (2), p.212-215

2019

Volltextzugriff (PDF)

Brain penetration of aprepitant, a substance P receptor antagonist, in ferrets

Drug metabolism and disposition, 2003-06, Vol.31 (6), p.785

2003

Volltextzugriff (PDF)

Detection of gender differences in rat lens proteins using 2-D-DIGE

Proteomics (Weinheim), 2006-01, Vol.6 (2), p.667-676

2006

Volltextzugriff (PDF)

Structural Optimization Affording 2-(R)-(1-(R)-3,5-Bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a Potent, Orally Active, Long-Acting Morpholine Acetal Human NK-1 Receptor Antagonist

Journal of medicinal chemistry, 1998-11, Vol.41 (23), p.4607-4614

1998

Volltextzugriff (PDF)

Spirocyclic NK1 antagonists II: [4.5]-Spiroethers

Bioorganic & medicinal chemistry letters, 2002-10, Vol.12 (19), p.2719-2722

2002

Volltextzugriff (PDF)

Novel lactam NK1 antagonists with anti-emetic activity

Bioorganic & medicinal chemistry letters, 2006-03, Vol.16 (5), p.1197-1201

2006

Volltextzugriff (PDF)

Selective, Orally Active γ-Aminobutyric AcidA α5 Receptor Inverse Agonists as Cognition Enhancers

Journal of medicinal chemistry, 2004-04, Vol.47 (9), p.2176-2179

2004

Volltextzugriff (PDF)

Imidazo[1,2- a]pyrimidines as functionally selective GABA A ligands

Bioorganic & medicinal chemistry letters, 2006-03, Vol.16 (5), p.1175-1179

2006

Volltextzugriff (PDF)

Imidazo[1,2 -a]pyrimidines as functionally selective GABAA ligands

Bioorganic & medicinal chemistry letters, 2006-03, Vol.16 (5), p.1175-1179

2006

Volltextzugriff (PDF)

In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonists

European journal of pharmacology, 1997-05, Vol.326 (2-3), p.201-209

1997

Volltextzugriff (PDF)

An Orally Active, Water-Soluble Neurokinin-1 Receptor Antagonist Suitable for Both Intravenous and Oral Clinical Administration

Journal of medicinal chemistry, 2001-11, Vol.44 (24), p.4296-4299

2001

Volltextzugriff (PDF)

The tachykinin NK1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferret

European journal of pharmacology, 1993-11, Vol.250 (1), p.R5-R6

1993

Volltextzugriff (PDF)

The Actions of Fenfluramine and Interaction with 5-HT3 Receptor-Antagonists to Inhibit Emesis in the Ferret

Journal of pharmacy and pharmacology, 1990-02, Vol.42 (2), p.94-101

1990

Volltextzugriff (PDF)

Novel lactam NK 1 antagonists with anti-emetic activity

Bioorganic & medicinal chemistry letters, 2006, Vol.16 (5), p.1197-1201

2006

Volltextzugriff (PDF)

Selective, orally active gamma-aminobutyric acidA alpha5 receptor inverse agonists as cognition enhancers

Journal of medicinal chemistry, 2004-04, Vol.47 (9), p.2176-2179

2004

Volltextzugriff (PDF)

Selective, Orally Active γ-Aminobutyric Acid A α5 Receptor Inverse Agonists as Cognition Enhancers

Journal of medicinal chemistry, 2004-04, Vol.47 (9), p.2176-2179

2004

Volltextzugriff (PDF)

In vitro and in vivo properties of 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA receptor alpha5 subtype-selective inverse agonist

The Journal of pharmacology and experimental therapeutics, 2009-11, Vol.331 (2), p.470

2009

Volltextzugriff (PDF)

Spirocyclic NK 1 antagonists II: [4.5]-spiroethers

Bioorganic & medicinal chemistry letters, 2002, Vol.12 (19), p.2719-2722

2002

Volltextzugriff (PDF)

Spirocyclic NK(1) antagonists II: [4.5]-spiroethers

Bioorganic & medicinal chemistry letters, 2002-10, Vol.12 (19), p.2719-2722

2002

Volltextzugriff (PDF)

Imidazo[1,2-a]pyrimidines as functionally selective GABA sub(A) ligands

Bioorganic & medicinal chemistry letters, 2006-01, Vol.16 (5), p.1175-1179

2006

Volltextzugriff (PDF)

Synthesis and Biological Evaluation of NK1 Antagonists Derived from L-Tryptophan

Journal of medicinal chemistry, 1995-03, Vol.38 (6), p.934-941

1995

Volltextzugriff (PDF)

Spirocyclic NK 1 Antagonists. Part 2. [4.5]‐Spiroethers

ChemInform, 2003-01, Vol.34 (2)

2003

Volltextzugriff (PDF)

Spirocyclic NK1 Antagonists. Part 2. [4.5]-Spiroethers

ChemInform, 2003-01, Vol.34 (2), p.no-no

2003

Volltextzugriff (PDF)

ICTV Virus Taxonomy Profile: Parvoviridae

Journal of general virology, 2019-03, Vol.100 (3), p.367-368

2019

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(48)

Publikationsform

Sprache

Englisch
(55)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(36)
Life Sciences & Biomedicine
(34)
Humans
(22)
Biological And Medical Sciences
(18)
Animals
(17)
Medical Sciences
(15)
Male
(13)
Female
(12)
Pharmacology. Drug Treatments
(12)
Pharmacology & Pharmacy
(11)
Chemistry, Medicinal
(8)
Ferrets
(8)
Middle Aged
(8)
Aged
(7)
Neuropharmacology
(7)
Neurokinin-1 Receptor Antagonists
(6)
Neurotransmitters. Neurotransmission. Receptors
(6)
Physical Sciences
(6)
Rats
(6)
Structure-Activity Relationship
(6)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Discovery of 4-ethoxy-7H-pyrrolo[2,3-d]pyrimidin-2-amines as potent, selective and orally bioavailable LRRK2 inhibitors

5-Substituted-N-pyridazinylbenzamides as potent and selective LRRK2 inhibitors: Improved brain unbound fraction enables efficacy

Brain penetration of aprepitant, a substance P receptor antagonist, in ferrets

Detection of gender differences in rat lens proteins using 2-D-DIGE

Structural Optimization Affording 2-(R)-(1-(R)-3,5-Bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a Potent, Orally Active, Long-Acting Morpholine Acetal Human NK-1 Receptor Antagonist

Spirocyclic NK1 antagonists II: [4.5]-Spiroethers

Novel lactam NK1 antagonists with anti-emetic activity

Selective, Orally Active γ-Aminobutyric AcidA α5 Receptor Inverse Agonists as Cognition Enhancers

Imidazo[1,2- a]pyrimidines as functionally selective GABA A ligands

Imidazo[1,2 -a]pyrimidines as functionally selective GABAA ligands

In vitro and in vivo predictors of the anti-emetic activity of tachykinin NK1 receptor antagonists

An Orally Active, Water-Soluble Neurokinin-1 Receptor Antagonist Suitable for Both Intravenous and Oral Clinical Administration

The tachykinin NK1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferret

The Actions of Fenfluramine and Interaction with 5-HT3 Receptor-Antagonists to Inhibit Emesis in the Ferret

Novel lactam NK 1 antagonists with anti-emetic activity

Selective, orally active gamma-aminobutyric acidA alpha5 receptor inverse agonists as cognition enhancers

Selective, Orally Active γ-Aminobutyric Acid A α5 Receptor Inverse Agonists as Cognition Enhancers

In vitro and in vivo properties of 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA receptor alpha5 subtype-selective inverse agonist

Spirocyclic NK 1 antagonists II: [4.5]-spiroethers

Spirocyclic NK(1) antagonists II: [4.5]-spiroethers

Imidazo[1,2-a]pyrimidines as functionally selective GABA sub(A) ligands

Synthesis and Biological Evaluation of NK1 Antagonists Derived from L-Tryptophan

Spirocyclic NK 1 Antagonists. Part 2. [4.5]‐Spiroethers

Spirocyclic NK1 Antagonists. Part 2. [4.5]-Spiroethers

ICTV Virus Taxonomy Profile: Parvoviridae

Suchergebnisse filtern